Skip to main content
. 2019 Jun 6;7(11):1270–1281. doi: 10.12998/wjcc.v7.i11.1270

Table 4.

Sensitivity analysis of adjusted hazard ratios for end-stage renal disease and death between the untreated and uninfected chronic kidney disease patients as well as between the treated and untreated chronic kidney disease patients

Adjusted HR for ESRD1
 Adjusted HR for death2
HR 95%CI P value HR 95%CI P value
Propensity score-matched CKD patients
Uninfected cohort (n = 3856) 1.00 Reference 1.00 Reference
Untreated HCV-infected cohort (n = 1928) 1.28 1.03-1.61 0.028 1.31 1.18-1.45 < 0.001
Propensity score-matched CKD patients
Untreated HCV-infected cohort (n = 1928) 1.00 Reference 1.00 Reference
Treated HCV-infected cohort (n = 482) 0.28 0.11-0.71 0.007 0.71 0.54-0.92 0.011
1

Adjusted for all covariates (age per year, sex, comorbidity, ACEI/ARB, enrollee category, number of medical visits, and Charlson comorbidity index score) and competing mortality;

2

Adjusted for all covariates (age per year, sex, comorbidity, ACEI/ARB, enrollee category, number of medical visits, and Charlson comorbidity index score). CKD: Chronic kidney disease; CI: Confidence interval; ACEI/ARB: Angiotensin converting enzyme inhibitor/angiotensin receptor blocker; ESRD: End-stage renal disease; HCV: Hepatitis C virus.